{"id":"W2171341132","doi":"10.1016/s0140-6736(02)08512-4","title":"Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial","year":2002,"lang":"en","type":"article","venue":"The Lancet","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4163,"is_retracted":false,"has_abstract":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Infliximab; Crohn's disease; Placebo; Internal medicine; Clinical endpoint; Odds ratio; Randomized controlled trial; Surgery; Gastroenterology; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}